BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24139244)

  • 1. [Progressive multifocal leukoencephalopathy and natalizumab-related immune reconstitution inflammatory syndrome: the advantage of MRI].
    Gibelin N; Daelman L; Goulipian S; Wynckel A; Chaunu MP; Tourbah A
    Rev Neurol (Paris); 2014 Jan; 170(1):48-50. PubMed ID: 24139244
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
    Tan LA; Lopes DK
    J Clin Neurosci; 2015 Oct; 22(10):1669-71. PubMed ID: 26115897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal supportive treatment in natalizumab-related PML in a MS patient.
    Lalive PH; Bridel C; Ferfoglia RI; Kaiser L; Du Pasquier R; Barkhof F; Haller S
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):354-5. PubMed ID: 24957322
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
    Métivier D; Arnaud FX; Dutasta F; Nguema B; Teriitehau C; Berets O; Baccialone J; Potet J
    Diagn Interv Imaging; 2013 Jan; 94(1):101-3. PubMed ID: 23228283
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.
    Igra MS; Paling D; Wattjes MP; Connolly DJA; Hoggard N
    Br J Radiol; 2017 Jun; 90(1074):20160721. PubMed ID: 28362522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.
    Kleinschmidt-DeMasters BK; Miravalle A; Schowinsky J; Corboy J; Vollmer T
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):604-17. PubMed ID: 22710964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?
    Wattjes MP; Verhoeff L; Zentjens W; Killestein J; van Munster ET; Barkhof F; van Eijk JJ
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1176-7. PubMed ID: 23695498
    [No Abstract]   [Full Text] [Related]  

  • 8. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
    Dahlhaus S; Hoepner R; Chan A; Kleiter I; Adams O; Lukas C; Hellwig K; Gold R
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1068-74. PubMed ID: 23606731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
    Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
    J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
    Blinkenberg M; Sellebjerg F; Leffers AM; Madsen CG; Sørensen PS
    Mult Scler; 2013 Aug; 19(9):1226-9. PubMed ID: 23508652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Too much of a good thing? IRIS with natalizumab-associated PML.
    Berger JR
    Neurology; 2011 Sep; 77(11):1033-4. PubMed ID: 21832217
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
    Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
    JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
    N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
    Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnosis of immune reconstitution inflammatory syndrome and progressive multifocal leukoencephalopathy after natalizumab withdrawal].
    Yakushina TI; Yakushin DM; Shtang IO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):116-121. PubMed ID: 36946407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological and clinical consequences of treating a patient with natalizumab.
    Schwab N; Höhn KG; Schneider-Hohendorf T; Metz I; Stenner MP; Jilek S; Du Pasquier RA; Gold R; Meuth SG; Ransohoff RM; Brück W; Wiendl H
    Mult Scler; 2012 Mar; 18(3):335-44. PubMed ID: 21908480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution inflammatory syndrome in natalizumab-associated PML.
    Hellwig K; Kleiter I; Gold R
    Neurology; 2012 Jan; 78(5):371; author reply 371. PubMed ID: 22291067
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune reconstitution inflammatory syndrome in natalizumab-associated PML.
    Phan-Ba R; Lommers E; Moonen G; Belachew S; Nath A
    Neurology; 2012 Jan; 78(1):73; author response 73. PubMed ID: 22201114
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
    Metz I; Radue EW; Oterino A; Kümpfel T; Wiendl H; Schippling S; Kuhle J; Sahraian MA; Gray F; Jakl V; Häusler D; Brück W
    Acta Neuropathol; 2012 Feb; 123(2):235-45. PubMed ID: 22057786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
    Décard BF; Haghikia A; Tönnes C; Thöne J; Lukas C; Chan A; Gold R
    Mult Scler; 2013 Feb; 19(2):249-51. PubMed ID: 22596228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.